A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic

References

• King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003;(1):CD002255.
   Google Scholar
• Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 2009;113:585–594.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002;100(Pt 1):1020–1037.
   PubMedGoogle Scholar
• Papatsonis DNM, Bos JM, Van Geijn HP, Lok CAR, Dekker GA. Nifedipine pharmacokinetics and plasma levels in the management of preterm labor. Am J Ther 2007;14:346–350.
   PubMedGoogle Scholar
• Ferguson JE, 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 1989;161(Pt 1):1485–1490.
   PubMedGoogle Scholar
• Andersson T, Flockhart DA, Goldstein DB, Huang SM, Kroetz DL, Milos PM, Ratain MJ, Thummel K. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther 2005;78:559–581.
   PubMed Web of Science ®Google Scholar
• Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, Guchelaar HJ. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med 2007;4: e209.
   PubMed Web of Science ®Google Scholar
• Patki KC, Von Moltke LL, Greenblatt DJ. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Drug Metabol Dispos 2003;31:938–944.
   PubMed Web of Science ®Google Scholar
• Cholerton S, Daly AK, Idle JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 1992;13:434–439.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Bell DA, Coulter SJ, Ghanayem B, Goldstein JA. Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype. J Pharmacol Exp Ther 2005;313:302–309.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Usmani KA, Chanas B, Ghanayem B, Xi T, Hodgson E, Mohrenweiser HW, Goldstein JA. Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics 2003;13:461–472.
   PubMedGoogle Scholar
• Zhao Y, Song M, Guan D, Bi S, Meng J, Li Q, Wang W. Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus. Transplant Proc 2005;37:178–181.
   PubMed Web of Science ®Google Scholar
• R Development Core Team.R: A language and environment for statistical computing.Vienna, Austria: R Foundation for Statistical Computing;2009. Available at: http://www.R-project.org. (accessed 7 August 2010).
   Google Scholar
• Kleinbloesem CH, van Brummelen P, van de Linde JA, Voogd PJ, Breimer DD. Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 1984;35:742–749.
   PubMed Web of Science ®Google Scholar
• Xie HG, Wood AJ, Kim RB, Stein CM, Wilkinson GR. Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics 2004;5:243–272.
   PubMed Web of Science ®Google Scholar
• Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, Wrighton SA. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 2002;30:883–891.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Onishi S, Fukuen S, Ikenaga Y, Ohno M, Hoshino K, Matsumoto K, Maihara A, Momiyama K, Ito T, et al. CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers. Pharmacogenomics J 2004;4:34–39.
   PubMedGoogle Scholar
• Papatsonis DNM, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int J Gynaecol Obstet 2003;82:5–10.
   PubMed Web of Science ®Google Scholar
• Prevost RR, Akl SA, Whybrew WD, Sibai BM. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension. Pharmacotherapy 1992;12:174–177.
   PubMed Web of Science ®Google Scholar
• Provost PR, Tremblay Y. Genes involved in the adrenal pathway of glucocorticoid synthesis are transiently expressed in the developing lung. Endocrinology 2005;146:2239–2245.
   PubMed Web of Science ®Google Scholar
• Haas DM, Hebert MF, Soldin OP, Flockhart DA, Madadi P, Nocon JJ, Chambers CD, Hankins GD, Clark S, Wisner KL, et al. Pharmacotherapy and pregnancy: highlights from the second international conference for individualized pharmacotherapy in pregnancy. Clin Transl Sci 2009;2:439–443.
   PubMed Web of Science ®Google Scholar
• Haas DM, Renbarger JL, Denne S, Ahmed MS, Easterling TR, Feibus K, Meslin EM, Koren G, Zajicek A, Snodgrass WR, et al. Pharmacotherapy and pregnancy: highlights from the first international conference for individualized pharmacotherapy in pregnancy. Clin Transl Sci 2009;2:11–14.
   PubMed Web of Science ®Google Scholar